Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Docetaxel Lipid Suspension
- Development stage
- Phase 4
- Lead developer
- Intas Pharmaceuticals
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
Docetaxel Lipid Suspension is a lipid-based formulation of the taxane antineoplastic agent docetaxel, developed by Cosmas Pharmaceuticals. It functions as a microtubule stabilizer by binding to the beta-subunit of tubulin, which inhibits the disassembly of microtubules and disrupts the mitotic spindle during cell division. This mechanism leads to cell cycle arrest at the G2/M phase and subsequent apoptosis in rapidly dividing cancer cells. The lipid suspension formulation is designed for intravenous administration and is approved for the treatment of various malignancies, including breast cancer, non-small cell lung cancer (NSCLC), and prostate cancer.
- Other names
- Docetaxel lipid suspension
02
Targets
TUBB (Tubulin (alpha and beta subunits))Microtubule
Beyond the preview
Go deeper on Docetaxel Lipid Suspension.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Docetaxel Lipid Suspension.